05/08/2020 7:58 am Welcome to isteroids.com - BLOG

Thursday 19, Aug 2010

  Long term use of steroids effective in reducing risk of Lymphoma In Rheumatoid Arthritis

Posted By
Pin it Share on Tumblr

Long term use of steroids effective in reducing risk of Lymphoma In Rheumatoid ArthritisAccording to data presented at EULAR 2007, the Annual European Congress of Rheumatology, in Barcelona, Spain, treatment with oral steroids for a period of two years or more can reduce the risk of rheumatoid arthritis (RA) related lymphoma.

It was disclosed that benefits of steroids were experienced regardless of when in the course of the disease the steroids were first administered.

Study author Dr Eva Baecklund of Uppsala University Hospital, Sweden said the data reveals a new aspect of steroid treatment.

Wednesday 07, Jul 2010

  Potential oral drug for rheumatoid arthritis discovered

Posted By
Pin it Share on Tumblr

Potential oral drug for rheumatoid arthritis discoveredCH-1504, considered by many as a potential oral drug for rheumatoid arthritis (RA), can motivate women to treat their condition earlier because it is less difficult than currently-available treatment options.

Chelsea Therapeutics, a pharmaceutical company specializing in treatment for rheumatoid arthritis and other immunological diseases, is currently on a developing spree to formulate an oral anti-inflammatory drug and conducting Phase I clinical trials in the UK with an aim to provide an amicable solution for this condition that is more prevalent in women and develops between ages of 35 and 50.

Dr. M. Gopal Nair, a professor and vice-chairman at the department of Biochemistry and Molecular Biology at the University of South Alabama, initially developed the CH-1504 therapy.

Monday 07, Jun 2010

  Joint damage from rheumatoid arthritis reduced by low steroid doses

Posted By
Pin it Share on Tumblr

Joint damage from rheumatoid arthritis reduced by low steroid dosesAccording to a review of evidence, low doses of steroids when used in the early phase of rheumatoid arthritis could inhibit joint damage.

It was remarked by review authors led by John Kirwan of Liverpool Women’s Hospital in England that treatment involving steroid pills with standard medications in the first two years after diagnosis should be made readily available to the patients.

The benefits from this treatment option were statistically significant when reviewers made use of statistical methods for focusing on only the highest-quality data.

Tuesday 25, May 2010

  Rheumatoid Arthritis inhibited by suicide molecule

Posted By
Pin it Share on Tumblr

Rheumatoid Arthritis inhibited by suicide moleculeA novel way for halting and even reversing rheumatoid arthritis has been developed by a researcher from Northwestern University Feinberg School of Medicine. This invention is concerned with the development of an imitation of a suicide molecule, which floats unidentified into overactive immune cells responsible for the disease.

Harris Perlman, the lead author and an associate professor of medicine at Feinberg, said the new therapy stops the disease cold in 75 percent of the mice.

The study was published in the February issue of Arthritis & Rheumatism.

Thursday 13, May 2010

  Prospective new treatment for severe asthma

Posted By
Pin it Share on Tumblr

Prospective new treatment for severe asthmaA prospective new treatment approach has been uncovered by researchers to treat severe asthma by blocking a powerful immune system chemical that is present in large quantities in patients, according to a small study in Thorax.

Severe asthma though rare can be noticed in around one in every ten asthmatics and progressively higher doses of steroids are required to be administered in an attempt to control symptoms.

The research team investigated tumor necrosis factor alpha (TNF alpha) that is found in many chronic inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and psoriasis.

Wednesday 12, May 2010

  CH-1504 may prove effective for rheumatoid arthritis

Posted By
Pin it Share on Tumblr

CH-1504 may prove effective for rheumatoid arthritisA potential oral drug for rheumatoid arthritis (RA), CH-1504, could encourage women in treating their condition earlier since it is less arduous than the presently available treatment forms.

Chelsea Therapeutics, a pharmaceutical company specializing in treatment for RA and other immunological diseases, is presently developing an oral anti-inflammatory medication and conducting Phase I clinical trials in the U.K. to offer a suitable solution for this condition that develops between the ages of 35 and 50 and is 2-3 times more prevalent in women.

CH-1504, the potential therapy, was initially developed by Dr. M. Gopal Nair, a professor and vice-chairman at the department of Biochemistry and Molecular Biology at the University of South Alabama.

Tuesday 11, May 2010

  Steroids in long run reduce lymphoma risk in Rheumatoid Arthritis

Posted By
Pin it Share on Tumblr

Steroids in long run reduce lymphoma risk in Rheumatoid ArthritisThe risk of rheumatoid arthritis (RA) related lymphoma is significantly reduced when oral steroid treatment is continued for a period of two years or more. This finding was disclosed by data presented at EULAR 2007, the Annual European Congress of Rheumatology, in Barcelona, Spain.

It was further disclosed that this set of benefits are attainable irrespective of when the steroids were first administered in course of the disease.

Study author Dr Eva Baecklund of Uppsala University Hospital, Sweden, said that long term steroid treatment may decrease the risk of malignant lymphomas (cancer in the immune system) in patients with severe rheumatoid arthritis.

Monday 26, Apr 2010

  Cancer and infertility can be prevented with new vasculitis therapy

Posted By
Pin it Share on Tumblr

Cancer and infertility can be prevented with new vasculitis therapyA drug previously approved for the treatment of non-Hodgkin’s B cell lymphoma and rheumatoid arthritis, Rituxan, was recently identified by researchers as a useful option to treat severe ANCA-associated vasculitis as effectively as cyclophosphamide, the present standard therapy.

The news was presented on October 18 at the annual meeting of the American College of Rheumatology in Philadelphia.

Robert Spiera, M.D., an associate attending rheumatologist at Hospital for Special Surgery in New York, said Rituxan is as effective as cyclophosphamide when it comes to promoting patients to go on remission without leading to infertility or causing secondary cancers.

Friday 23, Apr 2010

  Most women caught unaware of debilitating fracture risks

Posted By
Pin it Share on Tumblr

Most women caught unaware of debilitating fracture risksA serious international public health concern was recently raised by researchers after results from the Global Longitudinal Study of Osteoporosis in Women (GLOW) showed that women are at an increased risk for osteoporosis-associated fractures.

It was also suggested by the study that there is a complete failure among women to perceive the implications of having important risk factors.

Sunday 18, Apr 2010

  Arthritis pain can be reduced by injecting gold into knees

Posted By
Pin it Share on Tumblr

Arthritis pain can be reduced by injecting gold into kneesPatients affected by osteoarthritis can experience slowing down of the disease progression and pain getting eased with injecting gold into knees but this treatment form is not meant for every patient with rheumatoid arthritis, as per scientists.

As per the Arthritis Research Campaign, approximately 80 million people suffer from this condition and a further 350,000 people suffer from rheumatoid arthritis, which is an autoimmune joint disease where the joints in the body become inflamed.

It was remarked during the study that injecting gold into knees is not a same-treatment-for-all remedy as around 20-30 percent of the affected patients do not benefit from gold.

Next »